{"mainPropery":{"diseaseId":4155,"diseaseName":"Osteopetrosis","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/4155/osteopetrosis","synonyms":["Osteopetroses","Marble bones","Marble bone disease","Albers-Schonberg disease","Osteosclerosis fragilis","Albers-Schonberg osteopetrosis","Albers-Schoenberg disease","Osteopetrosis and related disorders"],"synonyms-with-source":[{"name":"Osteopetroses"},{"name":"Marble bones"},{"name":"Marble bone disease"},{"name":"Albers-Schonberg disease"},{"name":"Osteosclerosis fragilis"},{"name":"Albers-Schonberg osteopetrosis"},{"name":"Albers-Schoenberg disease"},{"name":"Osteopetrosis and related disorders","source":"OrphaData.Org"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"2781"},{"identifierType":"UMLS","identifierId":"C0029454"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases"}],"organizations":[{"resourceID":3386,"resourceName":"Osteopetrosis Support Trust","abbreviation":"","address1":"","address2":"","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"","phone":"","tty":"","tollFree":"","fax":"","email":"http://www.osteopetrosis-support-trust.org.uk/what-is-osteopetrosis/#contact","url":"http://www.osteopetrosis-support-trust.org.uk/","freeText":""},{"resourceID":3387,"resourceName":"The OsteoPETrosis Society","abbreviation":"OPETS","address1":"","address2":"","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"","phone":"980-292-3921","tty":"","tollFree":"","fax":"","email":"osteopetrosispatient@gmail.com,janecastello.opets@gmail.com","url":"http://www.osteopetrosis.org/","freeText":"Facebook page: https://www.facebook.com/osteopetrosis"}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=osteopetrosis%20%5Btitle%5D' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Osteopetrosis. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Osteopetroses%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Osteopetrosis. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/osteopetrosis' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Osteopetrosis. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/354/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/123968-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=2781' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/books/NBK1127/' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1538,"resourceId":2169,"resourceName":"MeSH®","descriptionText":"<a href='http://www.nlm.nih.gov/cgi/mesh/2010/MB_cgi?mode=&index=9605&view=expanded' target='_blank'>MeSH®</a> (Medical Subject Headings) is a terminology tool used by the National Library of Medicine. Click on the link to view information on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1545,"resourceId":2173,"resourceName":"Merck Manual","descriptionText":"The <a href='http://www.merckmanuals.com/home/children-s-health-issues/bone-disorders-in-children/osteopetroses' target='_blank'>Merck Manuals Online Medical Library</a> provides information on this condition for patients and caregivers.&nbsp;","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1591,"resourceId":2206,"resourceName":"Facebook Groups","descriptionText":"Visit the <a href='https://www.facebook.com/groups/osteopetrosis/' target='_blank'>Osteopetrosis</a> group on Facebook.","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":1700,"resourceId":2173,"resourceName":"Merck Manual","descriptionText":"The&nbsp;<a href='http://www.merckmanuals.com/professional/pediatrics/bone-disorders-in-children/overview-of-osteopetroses?qt=osteopetroses&alt=sh' target='_blank'>Merck Manual</a> for health care professionals provides information on&nbsp;Osteopetrosis.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2021,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='https://omim.org/phenotypicSeries/PS259700' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> lists the subtypes and associated genes for Osteopetrosis in a table called Phenotypic Series. Each entry in OMIM includes a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:13533' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2163,"resourceId":3372,"resourceName":"Good Days","descriptionText":"<a href='https://www.mygooddays.org/patients/diseases-covered/chronic-iron-overload' target='_blank'>Good Days</a> provides help to patients with life-altering conditions. Assistance includes help with the cost of medications and travel.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"}],"overviewQuestion":{"questionId":5647,"questionText":"What is osteopetrosis?","answerText":"<strong>Osteopetrosis</strong>&nbsp;refers to a group of rare, inherited skeletal disorders characterized by increased bone density and abnormal bone growth.[11886][11888] Symptoms and severity can vary greatly,&nbsp;ranging from neonatal onset with life-threatening complications (such as bone marrow failure) to the incidental finding of osteopetrosis on X-ray. Depending on severity and age of onset, features may include&nbsp;fractures, short stature, compressive neuropathies (pressure on the nerves), <a href=\"https://medlineplus.gov/ency/imagepages/19848.htm\" target=\"_blank\">hypocalcemia</a> with attendant tetanic <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003200.htm\" target=\"_blank\">seizures</a>,&nbsp;and life-threatening <a href=\"https://www.stjude.org/disease/pancytopenia.html\" target=\"_blank\">pancytopenia</a>. In rare cases, there may be neurological impairment or involvement of other body systems.[11886] Osteopetrosis may be caused by&nbsp;<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>&nbsp;in at least 10 <a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">genes</a>. Inheritance can be&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>,&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a>, or&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002051.htm\" target=\"_blank\">X-linked recessive</a>&nbsp;with the most severe forms being autosomal recessive. Management depends on the specific symptoms and severity and may include vitamin D supplements, various medications, and/or surgery. Adult osteopetrosis requires no treatment by itself, but complications may require intervention.[11887]","dateModified":"2016-07-20T00:00:00"},"basicQuestions":[{"questionId":10885,"questionText":"What causes osteopetrosis?","answerText":"The various types of osteopetrosis are caused by genetic changes (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in one of at least ten <a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">genes</a>.[11886] There is nothing a parent can do before, during or after a pregnancy to cause osteopetrosis in a child.\r\n<p>The genes associated with osteopetrosis are involved in the development and/or function of osteoclasts,[11885] cells that break down bone tissue when old bone is being replaced by new bone (bone remodeling). This process is necessary to keep bones strong and healthy. Mutations in these genes can lead to abnormal osteoclasts, or having too few osteoclasts. If this happens, old bone cannot be broken down as new bone is formed, so bones become too dense and prone to breaking.[4658]</p>\r\n<ul>\r\n    <li>Mutations in the&nbsp;<em><a href=\"https://ghr.nlm.nih.gov/gene/CLCN7\" target=\"_blank\">CLCN7</a></em>&nbsp;gene cause most cases of <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a>&nbsp;osteopetrosis, 10-15% of cases of <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>&nbsp;osteopetrosis (the most severe form), and all known cases of&nbsp;intermediate autosomal osteopetrosis.</li>\r\n    <li>Mutations in the <em><a href=\"https://ghr.nlm.nih.gov/gene/TCIRG1\" target=\"_blank\">TCIRG1</a></em> gene cause about 50% of cases of autosomal recessive osteopetrosis.</li>\r\n    <li>Mutations in the&nbsp;<em><a href=\"https://ghr.nlm.nih.gov/gene/IKBKG\" target=\"_blank\">IKBKG</a></em><a href=\"https://ghr.nlm.nih.gov/gene/IKBKG\" target=\"_blank\">&nbsp;</a>&nbsp;gene cause&nbsp;<a href=\"http://www.genome.gov/Glossary/index.cfm?id=209\" target=\"_blank\">X-linked</a>&nbsp;osteopetrosis.</li>\r\n    <li>Mutations in other genes are less common causes of osteopetrosis. </li>\r\n    <li>In about 30% percent of affected people, the cause is unknown.[4658]</li>\r\n</ul>\r\nPeople with questions about the specific cause of osteopetrosis in themselves or a family member are encouraged to speak with a genetics professional.","dateModified":"2016-07-20T09:37:00","resourceClassificationName":"Cause","references":[{"referenceId":4658,"authors":"","articleTitle":"Osteopetrosis","bookWebsiteJournalTitle":"Genetics Home Reference","date":"September 2010","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/osteopetrosis","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11885,"authors":"Zornitza Stark and Ravi Savarirayan","articleTitle":"Osteopetrosis","bookWebsiteJournalTitle":"Orphanet J Rare Dis","date":"2009","volume":"4:5","pages":"","url":"http://ojrd.biomedcentral.com/articles/10.1186/1750-1172-4-5","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11886,"authors":"Zornitza Stark and Ravi Savarirayan","articleTitle":"Osteopetrosis","bookWebsiteJournalTitle":"Orphanet","date":"October, 2012","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=2781","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":10890,"questionText":"How is osteopetrosis inherited?","answerText":"Inheritance of the various subtypes of osteopetrosis can be <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> (most commonly), <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>, or <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002051.htm\" target=\"_blank\">X-linked recessive</a>.[11886][4658] The most severe forms are autosomal recessive.[11886]\r\n<ul>\r\n    <li>In autosomal dominant inheritance, having a change (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a>) in only one copy of the responsible <a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a> in each cell is enough to cause features of the condition. Most people with autosomal dominant osteopetrosis inherit the condition from an affected parent.[4658] Each child of a person with this form has a 1 in 2 (50%) chance of being affected.</li>\r\n    <li>In autosomal recessive inheritance, in order to be affected a person must have a mutation in both copies of the responsible gene in each cell. Affected people inherit one mutated copy of the gene from each parent, who is referred to as a <a href=\"http://www.genome.gov/glossary/?id=23\" target=\"_blank\">carrier</a>. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has a:\r\n    <ul>\r\n        <li>25% (1 in 4) chance to be affected</li>\r\n        <li>50% (1 in 2) chance to be an unaffected carrier like each parent</li>\r\n        <li>25% chance to be unaffected <em>and</em> not be a carrier</li>\r\n    </ul>\r\n    </li>\r\n    <li>X-linked recessive conditions usually occur in males, who only have one X chromosome (and one Y chromosome). Females have two X chromosomes, so if they have a gene mutation on one of them, they still have a normal copy on their other X chromosome. For this reason, females are typically unaffected. While females can have an X-linked recessive condition, it is very rare.<br />\r\n    <br />\r\n    If a mother is a carrier of an X-linked recessive condition and the father is not, the risk to children depends on each child's sex.<br />\r\n    <ul>\r\n        <li>Each male child has a 50% chance to be unaffected, and a 50% chance to be affected</li>\r\n        <li>Each daughter has a 50% chance to be unaffected, and a 50% chance to be an unaffected carrier</li>\r\n    </ul>\r\n    If a father has the condition and the mother is not a carrier, all sons will be unaffected, and all daughters will be unaffected carriers.</li>\r\n</ul>","dateModified":"2016-07-20T09:41:00","resourceClassificationName":"Inheritance","references":[{"referenceId":4658,"authors":"","articleTitle":"Osteopetrosis","bookWebsiteJournalTitle":"Genetics Home Reference","date":"September 2010","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/osteopetrosis","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11885,"authors":"Zornitza Stark and Ravi Savarirayan","articleTitle":"Osteopetrosis","bookWebsiteJournalTitle":"Orphanet J Rare Dis","date":"2009","volume":"4:5","pages":"","url":"http://ojrd.biomedcentral.com/articles/10.1186/1750-1172-4-5","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11886,"authors":"Zornitza Stark and Ravi Savarirayan","articleTitle":"Osteopetrosis","bookWebsiteJournalTitle":"Orphanet","date":"October, 2012","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=2781","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":10896,"questionText":"Is genetic testing available for osteopetrosis?","answerText":"Yes. Genetic testing for the various subtypes of osteopetrosis is available.&nbsp;Genetic testing can be used to confirm the diagnosis and to differentiate between different subtypes of osteopetrosis. This may provide additional information regarding the long-term outlook (prognosis), likely response to treatment, and recurrence risks.[11885]<br />\r\n<br />\r\nThe <a href=\"The Genetic Testing Registry (GTR) is a central online resource for information about genetic tests. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional\" target=\"_blank\">Genetic Testing Registry</a> (GTR) is a central online resource for information about genetic tests. The intended audience for the GTR is health care professionals and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional. Click on the link above to view the information that the GTR provides about genetic testing for osteopetrosis.","dateModified":"2016-07-25T10:50:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":11885,"authors":"Zornitza Stark and Ravi Savarirayan","articleTitle":"Osteopetrosis","bookWebsiteJournalTitle":"Orphanet J Rare Dis","date":"2009","volume":"4:5","pages":"","url":"http://ojrd.biomedcentral.com/articles/10.1186/1750-1172-4-5","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":10886,"questionText":"How might osteopetrosis be treated?","answerText":"Treatment for osteopetrosis depends on the specific symptoms present and the severity in each person. Therefore, treatment options must be evaluated on an individual basis.<br />\r\n<br />\r\nNutritional support is important to improve growth and it also enhances responsiveness to other treatment options. A calcium-deficient diet has been beneficial for some affected people.<br />\r\n<br />\r\nTreatment is necessary for the infantile form:\r\n<ul>\r\n    <li>Vitamin D (<a href=\"https://medlineplus.gov/druginfo/meds/a682335.html\" target=\"_blank\">calcitriol</a>) appears to stimulate dormant osteoclasts, which stimulates bone resorption. Large doses of calcitriol with restricted calcium intake sometimes improves osteopetrosis dramatically, but the improvement seen with calcitrol is not sustained when therapy is stopped.</li>\r\n    <li>Gamma interferon can have long-term benefits. It improves white blood cell function (leading to fewer infections), decreases bone volume, and increases bone marrow volume.</li>\r\n    <li><a href=\"https://medlineplus.gov/ency/article/003683.htm\" target=\"_blank\">Erythropoietin</a> can be used for anemia, and <a href=\"http://www.nlm.nih.gov/medlineplus/steroids.html\" target=\"_blank\">corticosteroids</a>&nbsp; can be used for anemia and to stimulate bone resorption.[11887]</li>\r\n</ul>\r\n<p>Bone marrow transplantation (BMT) markedly improves some cases of severe, infantile osteopetrosis associated with bone marrow failure, and offers the best chance of longer-term survival for individuals with this type.[11887][11886]<br />\r\n<br />\r\nIn pediatric (childhood) osteopetrosis, surgery is sometimes needed because of fractures.<br />\r\n<br />\r\nAdult osteopetrosis typically does not require treatment, but complications of the condition may require intervention. Surgery may be needed for aesthetic or functional reasons (such as multiple fractures, deformity, and loss of function), or for severe degenerative joint disease.[11887]</p>","dateModified":"2016-07-20T09:38:00","resourceClassificationName":"Treatment","references":[{"referenceId":11886,"authors":"Zornitza Stark and Ravi Savarirayan","articleTitle":"Osteopetrosis","bookWebsiteJournalTitle":"Orphanet","date":"October, 2012","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=2781","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11887,"authors":"Robert Blank","articleTitle":"Osteopetrosis","bookWebsiteJournalTitle":"Medscape Reference","date":"December 17, 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/123968-overview","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":10888,"questionText":"What is the long-term outlook for people with osteopetrosis?","answerText":"The long-term-outlook (prognosis) for people with osteopetrosis depends on the subtype and the severity of the condition in each person.<br />\r\n<br />\r\nThe severe infantile forms of osteopetrosis are associated with shortened life expectancy, with most untreated children not surviving past their first decade.&nbsp;Bone marrow transplantation seems to have cured some infants with early-onset disease. However, the long-term prognosis after transplantation is unknown.[11888] For those with onset in childhood or adolescence, the effect of the condition depends on the specific symptoms (including how fragile the bones are and how much pain is present). Life expectancy in the adult-onset forms is normal.[11886]","dateModified":"2016-07-25T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":11886,"authors":"Zornitza Stark and Ravi Savarirayan","articleTitle":"Osteopetrosis","bookWebsiteJournalTitle":"Orphanet","date":"October, 2012","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=2781","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11888,"authors":"David D. Sherry Frank Pessler","articleTitle":"Osteopetroses","bookWebsiteJournalTitle":"Merck Manual","date":"2016","volume":"","pages":"","url":"http://www.merckmanuals.com/home/children-s-health-issues/bone-disorders-in-children/osteopetroses","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":57706,"abbreviatedInquiry":"Can you tell me about nutrition and how to reduce the intensity of osteopetrosis in the future?","caseQuestions":[{"questionId":10927,"questionText":"Are there specific diet recommendations for people with osteopetrosis?","answerText":"There is little information in the medical literature about nutrition and dietary recommendations for people with osteopetrosis. We are not aware of any specific dietary guidelines that have been proposed.<br />\r\n<br />\r\nGenerally, nutritional support in childhood is important to improve growth. It also may enhance responsiveness to other treatments.[11887]&nbsp;A low-calcium and high-phosphate diet in conjunction with oral <a href=\"https://medlineplus.gov/druginfo/meds/a601102.html\" target=\"_blank\">prednisone</a> has led to improvement in anemia, thrombocytopenia, and bone density in a few patients.[11968]&nbsp;However, some people may need calcium if <a href=\"http://www.merckmanuals.com/home/hormonal-and-metabolic-disorders/electrolyte-balance/hypocalcemia-low-level-of-calcium-in-the-blood\" target=\"_blank\">hypocalcemia</a> or <a href=\"https://medlineplus.gov/rickets.html\" target=\"_blank\">rickets</a> becomes a problem.&nbsp;<a href=\"https://ods.od.nih.gov/factsheets/VitaminD-Consumer/\" target=\"_blank\">Vitamin D</a> supplements may help by stimulating dormant osteoclasts, thus stimulating bone resorption.[11887]<br />\r\n&nbsp;&nbsp;<br />","dateModified":"2016-08-03T11:19:00","references":[{"referenceId":11887,"authors":"Robert Blank","articleTitle":"Osteopetrosis","bookWebsiteJournalTitle":"Medscape Reference","date":"December 17, 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/123968-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11968,"authors":"Williams R, Wang W","articleTitle":"Managing osteopetrosis in children: a nutrition challenge","bookWebsiteJournalTitle":"J Am Diet Assoc","date":"February, 1996","volume":"96(2)","pages":"172-175","url":"","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":10928,"questionText":"How might future symptoms or complications associated with osteopetrosis be prevented?","answerText":"Measures that may be taken to prevent signs and symptoms of osteopetrosis depend on the type of osteopetrosis a person has.\r\n<p>For people with&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>&nbsp;osteopetrosis, the most severe form, <a href=\"http://www.cancer.gov/types/childhood-cancers/child-hct-hp-pdq#link/_154_toc\" target=\"_blank\">allogenic hematopoietic stem cell transplantation</a> (HSCT) can cure the condition. Most signs and symptoms (bone sclerosis, bone marrow failure, and extramedullary hematopoiesis) can be prevented or reversed by HSCT. Secondary neurosensory impairments caused by nerve compression may be prevented by early HSCT, but not reversed when they are already present. The decision of whether a person is a candidate for HSCT is made on a case-by-case basis.<br />\r\n<br />\r\nFor people with <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a>  osteopetrosis, with onset usually in childhood or adulthood, good routine dental care and oral hygiene may help prevent <a href=\"http://www.mayoclinic.org/diseases-conditions/osteomyelitis/basics/definition/con-20025518\" target=\"_blank\">osteomyelitis</a> of the mandible (infection in the jaw bone).[11965]<br />\r\n<br />\r\nPeople with personal questions about options for preventing symptoms or complications of osteopetrosis should speak with their health care professional.</p>","dateModified":"2016-08-03T11:56:00","references":[{"referenceId":11965,"authors":"Cristina Sobacchi, Anna Villa, Ansgar Schulz,and Uwe Kornak","articleTitle":"CLCN7-Related Osteopetrosis","bookWebsiteJournalTitle":"GeneReviews","date":"June 9, 2016","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1127/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":10886,"questionText":"How might osteopetrosis be treated?","answerText":"Treatment for osteopetrosis depends on the specific symptoms present and the severity in each person. Therefore, treatment options must be evaluated on an individual basis.<br />\r\n<br />\r\nNutritional support is important to improve growth and it also enhances responsiveness to other treatment options. A calcium-deficient diet has been beneficial for some affected people.<br />\r\n<br />\r\nTreatment is necessary for the infantile form:\r\n<ul>\r\n    <li>Vitamin D (<a href=\"https://medlineplus.gov/druginfo/meds/a682335.html\" target=\"_blank\">calcitriol</a>) appears to stimulate dormant osteoclasts, which stimulates bone resorption. Large doses of calcitriol with restricted calcium intake sometimes improves osteopetrosis dramatically, but the improvement seen with calcitrol is not sustained when therapy is stopped.</li>\r\n    <li>Gamma interferon can have long-term benefits. It improves white blood cell function (leading to fewer infections), decreases bone volume, and increases bone marrow volume.</li>\r\n    <li><a href=\"https://medlineplus.gov/ency/article/003683.htm\" target=\"_blank\">Erythropoietin</a> can be used for anemia, and <a href=\"http://www.nlm.nih.gov/medlineplus/steroids.html\" target=\"_blank\">corticosteroids</a>&nbsp; can be used for anemia and to stimulate bone resorption.[11887]</li>\r\n</ul>\r\n<p>Bone marrow transplantation (BMT) markedly improves some cases of severe, infantile osteopetrosis associated with bone marrow failure, and offers the best chance of longer-term survival for individuals with this type.[11887][11886]<br />\r\n<br />\r\nIn pediatric (childhood) osteopetrosis, surgery is sometimes needed because of fractures.<br />\r\n<br />\r\nAdult osteopetrosis typically does not require treatment, but complications of the condition may require intervention. Surgery may be needed for aesthetic or functional reasons (such as multiple fractures, deformity, and loss of function), or for severe degenerative joint disease.[11887]</p>","dateModified":"2016-07-20T09:38:00","resourceClassificationName":"Treatment","references":[{"referenceId":11886,"authors":"Zornitza Stark and Ravi Savarirayan","articleTitle":"Osteopetrosis","bookWebsiteJournalTitle":"Orphanet","date":"October, 2012","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=2781","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11887,"authors":"Robert Blank","articleTitle":"Osteopetrosis","bookWebsiteJournalTitle":"Medscape Reference","date":"December 17, 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/123968-overview","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":10929,"questionText":"Who should I speak with regarding my questions about the management of osteopetrosis?","answerText":"A number of specialists may be needed to treat people with osteopetrosis. Medical management (aside from transplant) is usually done by an <a href=\"http://www.hormone.org/contact-a-health-professional/what-is-an-endocrinologist\" target=\"_blank\">endocrinologist</a> who is comfortable with, and knowledgeable of, metabolic bone disease. People with osteopetrosis who have scoliosis should see a spine specialist who is familiar with the condition. An orthopedic surgeon familiar with osteopetrosis should manage treatment for fractures and other problems with the bones and joints. It is also important to see an ophthalmologist (eye doctor) or neuro-ophthalmologist to follow or treat vision changes or vision loss.[11967]<br />\r\n<br />\r\n<a href=\"http://www.osteopetrosis.org/\" target=\"_blank\">The OsteoPETrosis Society website</a> provides the names of <a href=\"http://www.osteopetrosis.org/medical-advisory-council.html\" target=\"_blank\">several experts</a> and a physician referral list for people with osteopetrosis looking for doctors with knowledge of the condition.","dateModified":"2016-08-03T12:33:00","references":[{"referenceId":11967,"authors":"","articleTitle":"Autosomal Dominant Osteopetrosis","bookWebsiteJournalTitle":"The OsteoPETrosis Society","date":"2015","volume":"","pages":"","url":"http://www.osteopetrosis.org/autosomal-dominant-osteopetrosis-ado.html","authors2":"","placeOfPublication":"","publisher":""}]}]},{"caseId":57481,"abbreviatedInquiry":"I'm 22 years old and have osteopetrosis. I don't know how it happened but I want to know the source and preventive medicines for this. Will it affect my future life and my child?","caseQuestions":[{"questionId":10885,"questionText":"What causes osteopetrosis?","answerText":"The various types of osteopetrosis are caused by genetic changes (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in one of at least ten <a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">genes</a>.[11886] There is nothing a parent can do before, during or after a pregnancy to cause osteopetrosis in a child.\r\n<p>The genes associated with osteopetrosis are involved in the development and/or function of osteoclasts,[11885] cells that break down bone tissue when old bone is being replaced by new bone (bone remodeling). This process is necessary to keep bones strong and healthy. Mutations in these genes can lead to abnormal osteoclasts, or having too few osteoclasts. If this happens, old bone cannot be broken down as new bone is formed, so bones become too dense and prone to breaking.[4658]</p>\r\n<ul>\r\n    <li>Mutations in the&nbsp;<em><a href=\"https://ghr.nlm.nih.gov/gene/CLCN7\" target=\"_blank\">CLCN7</a></em>&nbsp;gene cause most cases of <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a>&nbsp;osteopetrosis, 10-15% of cases of <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>&nbsp;osteopetrosis (the most severe form), and all known cases of&nbsp;intermediate autosomal osteopetrosis.</li>\r\n    <li>Mutations in the <em><a href=\"https://ghr.nlm.nih.gov/gene/TCIRG1\" target=\"_blank\">TCIRG1</a></em> gene cause about 50% of cases of autosomal recessive osteopetrosis.</li>\r\n    <li>Mutations in the&nbsp;<em><a href=\"https://ghr.nlm.nih.gov/gene/IKBKG\" target=\"_blank\">IKBKG</a></em><a href=\"https://ghr.nlm.nih.gov/gene/IKBKG\" target=\"_blank\">&nbsp;</a>&nbsp;gene cause&nbsp;<a href=\"http://www.genome.gov/Glossary/index.cfm?id=209\" target=\"_blank\">X-linked</a>&nbsp;osteopetrosis.</li>\r\n    <li>Mutations in other genes are less common causes of osteopetrosis. </li>\r\n    <li>In about 30% percent of affected people, the cause is unknown.[4658]</li>\r\n</ul>\r\nPeople with questions about the specific cause of osteopetrosis in themselves or a family member are encouraged to speak with a genetics professional.","dateModified":"2016-07-20T09:37:00","resourceClassificationName":"Cause","references":[{"referenceId":4658,"authors":"","articleTitle":"Osteopetrosis","bookWebsiteJournalTitle":"Genetics Home Reference","date":"September 2010","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/osteopetrosis","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11885,"authors":"Zornitza Stark and Ravi Savarirayan","articleTitle":"Osteopetrosis","bookWebsiteJournalTitle":"Orphanet J Rare Dis","date":"2009","volume":"4:5","pages":"","url":"http://ojrd.biomedcentral.com/articles/10.1186/1750-1172-4-5","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11886,"authors":"Zornitza Stark and Ravi Savarirayan","articleTitle":"Osteopetrosis","bookWebsiteJournalTitle":"Orphanet","date":"October, 2012","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=2781","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":10896,"questionText":"Is genetic testing available for osteopetrosis?","answerText":"Yes. Genetic testing for the various subtypes of osteopetrosis is available.&nbsp;Genetic testing can be used to confirm the diagnosis and to differentiate between different subtypes of osteopetrosis. This may provide additional information regarding the long-term outlook (prognosis), likely response to treatment, and recurrence risks.[11885]<br />\r\n<br />\r\nThe <a href=\"The Genetic Testing Registry (GTR) is a central online resource for information about genetic tests. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional\" target=\"_blank\">Genetic Testing Registry</a> (GTR) is a central online resource for information about genetic tests. The intended audience for the GTR is health care professionals and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional. Click on the link above to view the information that the GTR provides about genetic testing for osteopetrosis.","dateModified":"2016-07-25T10:50:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":11885,"authors":"Zornitza Stark and Ravi Savarirayan","articleTitle":"Osteopetrosis","bookWebsiteJournalTitle":"Orphanet J Rare Dis","date":"2009","volume":"4:5","pages":"","url":"http://ojrd.biomedcentral.com/articles/10.1186/1750-1172-4-5","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":10886,"questionText":"How might osteopetrosis be treated?","answerText":"Treatment for osteopetrosis depends on the specific symptoms present and the severity in each person. Therefore, treatment options must be evaluated on an individual basis.<br />\r\n<br />\r\nNutritional support is important to improve growth and it also enhances responsiveness to other treatment options. A calcium-deficient diet has been beneficial for some affected people.<br />\r\n<br />\r\nTreatment is necessary for the infantile form:\r\n<ul>\r\n    <li>Vitamin D (<a href=\"https://medlineplus.gov/druginfo/meds/a682335.html\" target=\"_blank\">calcitriol</a>) appears to stimulate dormant osteoclasts, which stimulates bone resorption. Large doses of calcitriol with restricted calcium intake sometimes improves osteopetrosis dramatically, but the improvement seen with calcitrol is not sustained when therapy is stopped.</li>\r\n    <li>Gamma interferon can have long-term benefits. It improves white blood cell function (leading to fewer infections), decreases bone volume, and increases bone marrow volume.</li>\r\n    <li><a href=\"https://medlineplus.gov/ency/article/003683.htm\" target=\"_blank\">Erythropoietin</a> can be used for anemia, and <a href=\"http://www.nlm.nih.gov/medlineplus/steroids.html\" target=\"_blank\">corticosteroids</a>&nbsp; can be used for anemia and to stimulate bone resorption.[11887]</li>\r\n</ul>\r\n<p>Bone marrow transplantation (BMT) markedly improves some cases of severe, infantile osteopetrosis associated with bone marrow failure, and offers the best chance of longer-term survival for individuals with this type.[11887][11886]<br />\r\n<br />\r\nIn pediatric (childhood) osteopetrosis, surgery is sometimes needed because of fractures.<br />\r\n<br />\r\nAdult osteopetrosis typically does not require treatment, but complications of the condition may require intervention. Surgery may be needed for aesthetic or functional reasons (such as multiple fractures, deformity, and loss of function), or for severe degenerative joint disease.[11887]</p>","dateModified":"2016-07-20T09:38:00","resourceClassificationName":"Treatment","references":[{"referenceId":11886,"authors":"Zornitza Stark and Ravi Savarirayan","articleTitle":"Osteopetrosis","bookWebsiteJournalTitle":"Orphanet","date":"October, 2012","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=2781","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11887,"authors":"Robert Blank","articleTitle":"Osteopetrosis","bookWebsiteJournalTitle":"Medscape Reference","date":"December 17, 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/123968-overview","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":10888,"questionText":"What is the long-term outlook for people with osteopetrosis?","answerText":"The long-term-outlook (prognosis) for people with osteopetrosis depends on the subtype and the severity of the condition in each person.<br />\r\n<br />\r\nThe severe infantile forms of osteopetrosis are associated with shortened life expectancy, with most untreated children not surviving past their first decade.&nbsp;Bone marrow transplantation seems to have cured some infants with early-onset disease. However, the long-term prognosis after transplantation is unknown.[11888] For those with onset in childhood or adolescence, the effect of the condition depends on the specific symptoms (including how fragile the bones are and how much pain is present). Life expectancy in the adult-onset forms is normal.[11886]","dateModified":"2016-07-25T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":11886,"authors":"Zornitza Stark and Ravi Savarirayan","articleTitle":"Osteopetrosis","bookWebsiteJournalTitle":"Orphanet","date":"October, 2012","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=2781","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11888,"authors":"David D. Sherry Frank Pessler","articleTitle":"Osteopetroses","bookWebsiteJournalTitle":"Merck Manual","date":"2016","volume":"","pages":"","url":"http://www.merckmanuals.com/home/children-s-health-issues/bone-disorders-in-children/osteopetroses","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":10890,"questionText":"How is osteopetrosis inherited?","answerText":"Inheritance of the various subtypes of osteopetrosis can be <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> (most commonly), <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>, or <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002051.htm\" target=\"_blank\">X-linked recessive</a>.[11886][4658] The most severe forms are autosomal recessive.[11886]\r\n<ul>\r\n    <li>In autosomal dominant inheritance, having a change (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a>) in only one copy of the responsible <a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a> in each cell is enough to cause features of the condition. Most people with autosomal dominant osteopetrosis inherit the condition from an affected parent.[4658] Each child of a person with this form has a 1 in 2 (50%) chance of being affected.</li>\r\n    <li>In autosomal recessive inheritance, in order to be affected a person must have a mutation in both copies of the responsible gene in each cell. Affected people inherit one mutated copy of the gene from each parent, who is referred to as a <a href=\"http://www.genome.gov/glossary/?id=23\" target=\"_blank\">carrier</a>. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has a:\r\n    <ul>\r\n        <li>25% (1 in 4) chance to be affected</li>\r\n        <li>50% (1 in 2) chance to be an unaffected carrier like each parent</li>\r\n        <li>25% chance to be unaffected <em>and</em> not be a carrier</li>\r\n    </ul>\r\n    </li>\r\n    <li>X-linked recessive conditions usually occur in males, who only have one X chromosome (and one Y chromosome). Females have two X chromosomes, so if they have a gene mutation on one of them, they still have a normal copy on their other X chromosome. For this reason, females are typically unaffected. While females can have an X-linked recessive condition, it is very rare.<br />\r\n    <br />\r\n    If a mother is a carrier of an X-linked recessive condition and the father is not, the risk to children depends on each child's sex.<br />\r\n    <ul>\r\n        <li>Each male child has a 50% chance to be unaffected, and a 50% chance to be affected</li>\r\n        <li>Each daughter has a 50% chance to be unaffected, and a 50% chance to be an unaffected carrier</li>\r\n    </ul>\r\n    If a father has the condition and the mother is not a carrier, all sons will be unaffected, and all daughters will be unaffected carriers.</li>\r\n</ul>","dateModified":"2016-07-20T09:41:00","resourceClassificationName":"Inheritance","references":[{"referenceId":4658,"authors":"","articleTitle":"Osteopetrosis","bookWebsiteJournalTitle":"Genetics Home Reference","date":"September 2010","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/osteopetrosis","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11885,"authors":"Zornitza Stark and Ravi Savarirayan","articleTitle":"Osteopetrosis","bookWebsiteJournalTitle":"Orphanet J Rare Dis","date":"2009","volume":"4:5","pages":"","url":"http://ojrd.biomedcentral.com/articles/10.1186/1750-1172-4-5","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11886,"authors":"Zornitza Stark and Ravi Savarirayan","articleTitle":"Osteopetrosis","bookWebsiteJournalTitle":"Orphanet","date":"October, 2012","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=2781","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":10889,"questionText":"Will osteopetrosis affect my child?","answerText":"The chance for a person with osteopetrosis to have an affected child depends on the type of osteopetrosis present and how it is inherited. For example, for those with the more common adult form (inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a>&nbsp;manner), there is a 50% chance to pass the disease-causing gene to each child.<br />\r\n<br />\r\nPeople with personal questions about the chance to have an affected child are encouraged to speak with a&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/geneticcounseling.html\" target=\"_blank\">genetic counselor</a>&nbsp;or other genetics professional. A genetics professional can help by:\r\n<ul>\r\n    <li>thoroughly evaluating the family history</li>\r\n    <li>addressing questions and concerns</li>\r\n    <li>assessing recurrence risks</li>\r\n    <li>facilitating genetic testing if desired</li>\r\n    <li>discussing reproductive options</li>\r\n</ul>","dateModified":"2016-07-25T00:00:00","references":[]},{"questionId":2567,"questionText":"How can I find a genetics professional in my area?","answerText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by  the <a href=\"https://www.acmg.net/ACMG/Find_Genetic_Services/ACMG/ISGweb/FindaGeneticService.aspx?hkey=720856ab-a827-42fb-a788-b618b15079f9\" target=\"_blank\">American College of Medical Genetics</a>&nbsp;and the&nbsp;<a href=\"https://www.findageneticcounselor.com/\" target=\"_blank\">National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also <a href=\"http://ghr.nlm.nih.gov/handbook/consult?show=all\" target=\"_blank\">learn more about genetic consultations</a> from Genetics Home Reference.","dateModified":"2017-12-06T00:00:00","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":14487,"phenoTypeName":"Abnormal cortical bone morphology","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9385,"phenoTypeName":"Abnormal cranial nerve morphology","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":4941,"phenoTypeName":"Abnormal pelvis bone ossification","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14124,"phenoTypeName":"Abnormality of the ribs","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11816,"phenoTypeName":"Abnormality of vertebral epiphysis morphology","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5613,"phenoTypeName":"Abnormality of vision","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13280,"phenoTypeName":"Bone pain","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":12141,"phenoTypeName":"Cranial nerve paralysis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5668,"phenoTypeName":"Craniosynostosis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13043,"phenoTypeName":"Fever","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":4082,"phenoTypeName":"Growth delay","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11303,"phenoTypeName":"Hearing impairment","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":4309,"phenoTypeName":"Hypocalcemia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13828,"phenoTypeName":"Hypophosphatemia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13313,"phenoTypeName":"Lymphadenopathy","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9851,"phenoTypeName":"Macrocephaly","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10592,"phenoTypeName":"Osteomyelitis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14076,"phenoTypeName":"Osteopetrosis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":2230,"phenoTypeName":"Peripheral neuropathy","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10294,"phenoTypeName":"Petechiae","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10710,"phenoTypeName":"Recurrent fractures","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10304,"phenoTypeName":"Reduced bone mineral density","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10783,"phenoTypeName":"Sandwich appearance of vertebral bodies","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10764,"phenoTypeName":"Sclerotic vertebral endplates","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8265,"phenoTypeName":"Bruising susceptibility","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10673,"phenoTypeName":"Immunodeficiency","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13075,"phenoTypeName":"Leukocytosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14680,"phenoTypeName":"Persistence of primary teeth","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5635,"phenoTypeName":"Abnormal chorioretinal morphology","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8972,"phenoTypeName":"Abnormal pulmonary valve morphology","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9566,"phenoTypeName":"Bone marrow hypocellularity","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10149,"phenoTypeName":"Carious teeth","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":7947,"phenoTypeName":"Genu valgum","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8715,"phenoTypeName":"Intellectual disability","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10381,"phenoTypeName":"Mandibular prognathia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10109,"phenoTypeName":"Nystagmus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10711,"phenoTypeName":"Osteoarthritis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13049,"phenoTypeName":"Renal tubular acidosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11087,"phenoTypeName":"Sleep apnea","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3886,"phenoTypeName":"Splenomegaly","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":15512,"phenoTypeName":"Thrombocytopenia","frequencyText":"Occasional","percentRanges":"5%-29%"}],"medicalProducts":[{"productId":272,"genericName":"Interferon gamma-1b","tradeName":"Actimmune®","tradeLink":"http://www.actimmune.com/","manufacturer":"","sponsor":"InterMune , Inc.","indication":"Delaying time to disease progression in patients with severe, malignant osteopetrosis.","drugInformationLink":"http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=Actimmune","medlinePlusLink":""}],"EncodedName":"Osteopetrosis"}